Terms: = Prostate cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523
150 results:
1. Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway.
Asdemir A; Özgür A
Med Oncol; 2024 Mar; 41(4):83. PubMed ID: 38436810
[TBL] [Abstract] [Full Text] [Related]
2. Risk of bladder, kidney and prostate cancer from occupational exposure to welding fumes: a systematic review and meta-analysis.
Collatuzzo G; Hamdani M; Boffetta P
Int Arch Occup Environ Health; 2024 Apr; 97(3):221-230. PubMed ID: 38231405
[TBL] [Abstract] [Full Text] [Related]
3. The current status of clinical trials on cancer and age disparities among the most common cancer trial participants.
Zhao S; Miao M; Wang Q; Zhao H; Yang H; Wang X
BMC Cancer; 2024 Jan; 24(1):30. PubMed ID: 38166779
[TBL] [Abstract] [Full Text] [Related]
4. PTEN-regulated PI3K-p110 and AKT isoform plasticity controls metastatic prostate cancer progression.
Miller KA; Degan S; Wang Y; Cohen J; Ku SY; Goodrich DW; Gelman IH
Oncogene; 2024 Jan; 43(1):22-34. PubMed ID: 37875657
[TBL] [Abstract] [Full Text] [Related]
5. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in prostate cancer Cells.
Sanchez-Hernandez ES; Ochoa PT; Suzuki T; Ortiz-Hernandez GL; Unternaehrer JJ; Alkashgari HR; Diaz Osterman CJ; Martinez SR; Chen Z; Kremsky I; Wang C; Casiano CA
Cells; 2023 Aug; 12(16):. PubMed ID: 37626856
[TBL] [Abstract] [Full Text] [Related]
6. A prospective head-to-head comparison of [
Wang G; Li L; Zhu M; Zang J; Wang J; Wang R; Yan W; Zhu L; Kung HF; Zhu Z
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3126-3136. PubMed ID: 37233785
[TBL] [Abstract] [Full Text] [Related]
7. Treatment burden in individuals living with and beyond cancer: A systematic review of qualitative literature.
Adam R; Nair R; Duncan LF; Yeoh E; Chan J; Vilenskaya V; Gallacher KI
PLoS One; 2023; 18(5):e0286308. PubMed ID: 37228101
[TBL] [Abstract] [Full Text] [Related]
8. Over-Expression of LEDGF/p75 in HEp-2 Cells Enhances Autoimmune IgG Response in Patients with Benign Prostatic Hyperplasia-A Novel Diagnostic Approach with Therapeutic Consequence?
Liedtke V; Rose L; Hiemann R; Nasser A; Rödiger S; Bonaventura A; Winkler L; Sowa M; Stöckle M; Schierack P; Junker K; Roggenbuck D
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047137
[TBL] [Abstract] [Full Text] [Related]
9. Extended therapy with [
Mader N; Nguyen Ngoc C; Kirkgöze B; Baumgarten J; Groener D; Klimek K; Happel C; Tselis N; Chun FKH; Grünwald F; Sabet A
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1811-1821. PubMed ID: 36702927
[TBL] [Abstract] [Full Text] [Related]
10. Urinary microbiota and prostatic diseases: the key for the lock? A systematic review.
Mjaess G; Karam A; Roumeguère T; Diamand R; Aoun F; McVary K; Moul JW; De Nunzio C; Albisinni S
Prostate Cancer Prostatic Dis; 2023 Sep; 26(3):451-460. PubMed ID: 36209236
[TBL] [Abstract] [Full Text] [Related]
11. Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed cancer Cells.
Tezcan G; Alsaadi M; Hamza S; Garanina EE; Martynova EV; Ziganshina GR; Farukshina ER; Rizvanov AA; Khaiboullina SF
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012769
[TBL] [Abstract] [Full Text] [Related]
12. Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology.
Cao H; Wang D; Gao R; Li C; Feng Y; Chen L
PeerJ; 2022; 10():e13481. PubMed ID: 35782093
[TBL] [Abstract] [Full Text] [Related]
13. Feasibility, pitfalls and results of a structured concept-development phase for a randomized controlled phase III trial on radiotherapy in primary prostate cancer patients.
Spohn SKB; Adebahr S; Huber M; Jenkner C; Wiehle R; Nagavci B; Schmucker C; Carl EG; Chen RC; Weber WA; Mix M; Rühle A; Sprave T; Nicolay NH; Gratzke C; Benndorf M; Wiegel T; Weis J; Baltas D; Grosu AL; Zamboglou C
BMC Cancer; 2022 Mar; 22(1):337. PubMed ID: 35351058
[TBL] [Abstract] [Full Text] [Related]
14. Blocking PI3K p110β Attenuates Development of PTEN-Deficient Castration-Resistant prostate cancer.
Gao X; Wang Y; Ribeiro CF; Manokaran C; Chang H; Von T; Rodrigues S; Cizmecioglu O; Jia S; Korpal M; Korn JM; Wang Z; Schmit F; Jiang L; Pagliarini R; Yang Y; Sethi I; Signoretti S; Yuan GC; Loda M; Zhao JJ; Roberts TM
Mol Cancer Res; 2022 May; 20(5):673-685. PubMed ID: 35105671
[TBL] [Abstract] [Full Text] [Related]
15. Evaluation of the Anticancer Potential of Crude, Irradiated
Abdelglil MI; Abdallah SO; El-Desouky MA; Alfaifi MY; Elbehairi SEI; Mohamed AF
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834153
[TBL] [Abstract] [Full Text] [Related]
16. Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.
Li S; Wu R; Wang L; Dina Kuo HC; Sargsyan D; Zheng X; Wang Y; Su X; Kong AN
Mol Carcinog; 2022 Jan; 61(1):111-121. PubMed ID: 34727410
[TBL] [Abstract] [Full Text] [Related]
17. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant prostate cancer Cells.
Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
[TBL] [Abstract] [Full Text] [Related]
18. [Comparison on efficacy between fascia-oriented versus vascular-oriented lateral lymph node dissection in patients with rectal cancer].
Wang ZJ; Liu Z; Liang JW; Zhang MG; Mei SW; Shen HY; Chen JN; Li J; Zhao FQ; Wei FZ; Xiao TX; Liu Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jul; 24(7):611-618. PubMed ID: 34289546
[No Abstract] [Full Text] [Related]
19. LEDGF/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators.
Canella A; Van Belle S; Brouns T; Nigita G; Carlon MS; Christ F; Debyser Z
Cancer Gene Ther; 2022 Feb; 29(2):133-140. PubMed ID: 33795806
[TBL] [Abstract] [Full Text] [Related]
20. Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium.
Amadou A; Freisling H; Jenab M; Tsilidis KK; Trichopoulou A; Boffetta P; Van Guelpen B; Mokoroa O; Wilsgaard T; Kee F; Schöttker B; Ordóñez-Mena JM; Männistö S; Söderberg S; Vermeulen RCH; Quirós JR; Liao LM; Sinha R; Kuulasmaa K; Brenner H; Romieu I
Br J Cancer; 2021 May; 124(11):1882-1890. PubMed ID: 33772152
[TBL] [Abstract] [Full Text] [Related]
[Next]
